Loading clinical trials...
Loading clinical trials...
A Phase 2, Multi-Center, Randomized, Multiple Arm, Controlled Pilot Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Reducing Post- Keloidectomy Keloid Recurrence
Conditions
Interventions
STP705
Placebo
Locations
3
United States
Investigate MD
Scottsdale, Arizona, United States
Center for Clinical and Cosmetic Research
Aventura, Florida, United States
Schweiger Dermatology
Hackensack, New Jersey, United States
Start Date
April 29, 2021
Primary Completion Date
May 17, 2023
Completion Date
May 17, 2023
Last Updated
March 19, 2024
NCT07336368
NCT06373458
NCT06806735
NCT07413497
NCT07201766
NCT04214483
Lead Sponsor
Sirnaomics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions